S&P 500 (NYSE:SPY) component Allergan, Inc. (NYSE:AGN) will unveil its latest earnings on Wednesday, May 2, 2012. Allergan is a global specialty health care company. It discovers, develops, and commercializes innovative pharmaceuticals, biologics, and medical devices, as well as over-the-counter products.
Allergan, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of 87 cents per share, a rise of 13% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 90 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 87 cents during the last month. Analysts are projecting profit to rise by 14.5% versus last year to $4.18.
Past Earnings Performance: The company met estimates last quarter after beating the forecasts in the prior two. In the fourth quarter of the last fiscal year, the company reported profit of $1 per share versus a mean estimate of net income of $1 per share. In the third quarter of the last fiscal year, the company beat estimates by 2 cents.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts predict a rise of 8.7% in revenue from the year-earlier quarter to $1.38 billion.
Analyst Ratings: Analysts are bullish on this stock, with 14 analysts rating it as a buy, one rating it as a sell and eight rating it as a hold.
A Look Back: In the fourth quarter of the last fiscal year, profit rose 6.3% to $279.8 million (90 cents a share) from $263.1 million (87 cents a share) the year earlier, meeting analyst expectations. Revenue rose 7.1% to $1.4 billion from $1.31 billion.
On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 10.1% in the first quarter of the last fiscal year, 13.6% in the second quarter of the last fiscal year and 9.9% in the third quarter of the last fiscal year before increasing again in the fourth quarter of the last fiscal year of the last fiscal year.
Stock Price Performance: Between January 31, 2012 and April 26, 2012, the stock price rose $8.52 (9.7%), from $87.86 to $96.38. The stock price saw one of its best stretches over the last year between October 7, 2011 and October 14, 2011, when shares rose for six straight days, increasing 5.8% (+$4.70) over that span. It saw one of its worst periods between January 25, 2012 and February 2, 2012 when shares fell for seven straight days, dropping 5% (-$4.46) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: